سعر ميدريلاكسميدين 200مكجم/50مل فيال محلول وريدي 2024

Dexmedetomidine 4 mcg/ml (200 mcg/50 ml) ready-to-use solution for intravenous infusion in a 50 ml glass vial; made by Arabcomed, Egypt.

• Sedation of initially intubated patients during treatment in an intensive care setting; continuous infusion should not exceed 24 hours.Population: Intubated ICU patientsArabcomed (Arab Company for Medical Products) - manufacturer website
• Sedation of non-intubated patients prior to and/or during surgical and other procedures.Population: Non-intubated patientsArabcomed (Arab Company for Medical Products) - manufacturer website
• Sedation of initially intubated and mechanically ventilated adult patients during treatment in an intensive care setting (continuous infusion not exceeding 24 hours).Population: AdultsDailyMed (U.S. National Library of Medicine)

• Most common adverse reactions in adults (incidence >2%): hypotension, bradycardia and dry mouth.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Most common adverse reactions in pediatric procedural sedation: bradypnea, bradycardia, hypertension and hypotension.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• The US label lists no contraindications (Contraindications: None).International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Hypotension, bradycardia and sinus arrest have occurred, particularly with rapid IV or bolus administration and in patients with high vagal tone; use with caution in advanced heart block or severe ventricular dysfunction.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Transient hypertension may occur during the loading dose; reducing the loading infusion rate may be desirable.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Patients may be arousable and alert when stimulated; this alone should not be taken as lack of efficacy.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Anesthetics, sedatives, hypnotics and opioidsCo-administration is likely to enhance their effects; dose reduction of dexmedetomidine or of the concomitant drug may be required.DailyMed (U.S. National Library of Medicine)

• Available data from published studies in pregnant women have not identified a drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes; dexmedetomidine crosses the placenta.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Dexmedetomidine is present in human milk; monitor breastfed infants exposed through breast milk for irritability.International label, same formulation · DailyMed (U.S. National Library of Medicine)

English text not available for this section.